haloperidol and l 365260

haloperidol has been researched along with l 365260 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B1
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD1
Ibii, N; Ikeda, M; Kihara, T; Matsushita, A1
Ashby, CR; Minabe, Y; Wang, RY1
Bourin, M; Bradwejn, J; Harro, J; Kõks, S; Lang, A; Männistö, PT; Oreland, L; Soosaar, A; Vasar, E; Volke, V1
Corrigall, WA; Higgins, GA; Joharchi, N; Sellers, EM; Wang, Y1

Other Studies

6 other study(ies) available for haloperidol and l 365260

ArticleYear
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
    Journal of medicinal chemistry, 2000, Jun-01, Volume: 43, Issue:11

    Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
    Bioorganic & medicinal chemistry letters, 2004, Sep-20, Volume: 14, Issue:18

    Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2004
Ceruletide, a CCK-like peptide, attenuates dopamine release from the rat striatum via a central site of action.
    Brain research, 1992, Aug-21, Volume: 588, Issue:2

    Topics: Animals; Benzodiazepinones; Ceruletide; Cholecystokinin; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine; Haloperidol; Male; Phenylurea Compounds; Potassium; Proglumide; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Cholecystokinin; Vagotomy

1992
The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons.
    Brain research, 1991, May-17, Volume: 549, Issue:1

    Topics: Animals; Benzodiazepinones; Cholecystokinin; Clozapine; Devazepide; Dopamine; Haloperidol; Male; Mesencephalon; Neurons; Phenylurea Compounds; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Reference Values

1991
Role of N-methyl-D-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behaviour in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 1995, Volume: 351, Issue:4

    Topics: Aggression; Animals; Apomorphine; Benzodiazepinones; Brain Chemistry; Clozapine; Devazepide; Dizocilpine Maleate; Haloperidol; Male; Phenylurea Compounds; Radioligand Assay; Rats; Rats, Wistar; Receptors, Cholecystokinin; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate

1995
The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol.
    Brain research, 1994, Mar-21, Volume: 640, Issue:1-2

    Topics: Animals; Benzodiazepinones; Cholecystokinin; Cocaine; Conditioning, Operant; Cues; Devazepide; Discrimination, Psychological; Dopamine Antagonists; Food; Haloperidol; Heroin; Male; Morphine; Narcotics; Phenylurea Compounds; Rats; Rats, Wistar; Receptors, Cholecystokinin; Self Administration

1994